Abstract
Background
Variants of the NUS1 gene have been associated with an extensive spectrum of phenotypes, including epilepsy, intellectual disability, cerebellar ataxia, Parkinson’s disease, dystonia, and congenital disorder of glycosylation. It is rarely reported in progressive myoclonus epilepsy (PME).
Methods and results
Herein, we report the case of PME caused by a novel de novo NUS1 missense variant (c.302T>A, p.Met101Lys). In addition, we reviewed the current literature of NUS1-associated PME. At present, five patients with NUS1 variants and PME have been reported in the literature. Due to limited cases reported, the relationship between NUS1 variants and PME is not well-established.
Conclusions
Our case provides further evidence of the role of NUS1 variants in PME. These findings expand the clinical phenotypes of NUS1 variants, which should be included in the PME genetic screening panel.
Similar content being viewed by others
Data availability
The raw data presented in this article will be available by the authors, and reasonable requests to access the data should be directed to the corresponding author after legal permission.
References
Yu SH, Wang T, Wiggins K, Louie RJ, Merino EF, Skinner C, Cassera MB, Meagher K, Goldberg P, Rismanchi N, Chen D, Lyons MJ, Flanagan-Steet H, Steet R (2021) Lysosomal cholesterol accumulation contributes to the movement phenotypes associated with NUS1 haploinsufficiency. Gene Med : Off J Am College Med Gene 23(7):1305–1314
Park EJ, Grabińska KA, Guan Z, Stránecký V, Hartmannová H, Hodaňová K, Barešová V, Sovová J, Jozsef L, Ondrušková N, Hansíková H, Honzík T, Zeman J, Hůlková H, Wen R, Kmoch S, Sessa WC (2014) Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation. Cell Metab 20(3):448–457
Zhang P, Cui D, Liao P, Yuan X, Yang N, Zhen Y, Yang J, Huang Q (2021) Case report: clinical features of a Chinese boy with epileptic seizures and intellectual disabilities who carries a truncated NUS1 variant. Front Pediatr 9:725231
Bustos BI, Bandres-Ciga S, Gibbs JR, Krainc D, Mencacci NE, Gan-Or Z, Lubbe SJ (2021) Replication assessment of NUS1 variants in Parkinson’s disease. Neurobiol Aging 101(300):e1-300.e3
Gunzler SA, DeBrosse SD (2021) Generalized dystonia as a prominent feature in a case of NUS1 gene mutation, The Canadian journal of neurological sciences. Le J Canadien des Sci Neurol 48(3):433–434
Courage C, Oliver KL, Park EJ, Cameron JM, Grabińska KA, Muona M, Canafoglia L, Gambardella A, Said E, Afawi Z, Baykan B, Brandt C, di Bonaventura C, Chew HB, Criscuolo C, Dibbens LM, Castellotti B, Riguzzi P, Labate A, Filla A, Giallonardo AT, Berecki G, Jackson CB, Joensuu T, Damiano JA, Kivity S, Korczyn A, Palotie A, Striano P, Uccellini D, Giuliano L, Andermann E, Scheffer IE, Michelucci R, Bahlo M, Franceschetti S, Sessa WC, Berkovic SF, Lehesjoki AE (2021) Progressive myoclonus epilepsies-residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes. Am J Hum Genet 108(4):722–738
Franceschetti S, Michelucci R, Canafoglia L, Striano P, Gambardella A, Magaudda A, Tinuper P, La Neve A, Ferlazzo E, Gobbi G, Giallonardo AT, Capovilla G, Visani E, Panzica F, Avanzini G, Tassinari CA, Bianchi A, Zara F (2014) Progressive myoclonic epilepsies: definitive and still undetermined causes. Neurology 82(5):405–411
Canafoglia L, Franceschetti S, Gambardella A, Striano P, Giallonardo AT, Tinuper P, Di Bonaventura C, Michelucci R, Ferlazzo E, Granata T, Magaudda A, Licchetta L, Filla A, La Neve A, Riguzzi P, Cantisani TA, Fanella M, Castellotti B, Gellera C, Bahlo M, Zara F, Courage C, Lehesjoki AE, Oliver KL, Berkovic SF (2021) Progressive myoclonus epilepsies: diagnostic yield with next-generation sequencing in previously unsolved cases. Neurology Genetics 7(6):e641
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Gene Med : Off J Am College Med Gene 17(5):405–424
Fraiman P, Maia-de-Oliveira JP, Moreira-Neto M, Godeiro-Junior C (2021) Psychosis in NUS1 de novo mutation: new phenotypical presentation. Clin Genet 99(3):475–476
Den K, Kudo Y, Kato M, Watanabe K, Doi H, Tanaka F, Oguni H, Miyatake S, Mizuguchi T, Takata A, Miyake N, Mitsuhashi S, Matsumoto N (2019) Recurrent NUS1 canonical splice donor site mutation in two unrelated individuals with epilepsy, myoclonus, ataxia and scoliosis - a case report. BMC Neurol 19(1):253
Riboldi GM, Monfrini E, Stahl C, Frucht SJ (2022) NUS1 and Epilepsy-myoclonus-ataxia Syndrome: An Under-recognized Entity? Tremor Other Hyperkinetic Movements (New York, NY) 12:21
Rossi M, van der Veen S, Merello M, Tijssen MAJ, van de Warrenburg B (2021) Myoclonus-ataxia syndromes: a diagnostic approach. Movement Disord Clin Pract 8(1):9–24
Orsini A, Valetto A, Bertini V, Esposito M, Carli N, Minassian BA, Bonuccelli A, Peroni D, Michelucci R, Striano P (2019) The best evidence for progressive myoclonic epilepsy: a pathway to precision therapy. Seizure 71:247–257
Jiang L, Mei JP, Zhao YW, Zhang R, Pan HX, Yang Y, Sun QY, Xu Q, Yan XX, Tan JQ, Li JC, Tang BS, Guo JF (2022) Low-frequency and rare coding variants of NUS1 contribute to susceptibility and phenotype of Parkinson’s disease. Neurobiol Aging 110:106–112
Monfrini E, Miller C, Frucht SJ, Di Fonzo A, Riboldi GM (2022) Progressive myoclonus without epilepsy due to a NUS1 frameshift insertion: dyssynergia cerebellaris myoclonica revisited. Parkinsonism Relat Disord 98:53–55
Araki K, Nakamura R, Ito D, Kato K, Iguchi Y, Sahashi K, Toyama M, Hamada K, Okamoto N, Wada Y, Nakamura T, Ogi T, Katsuno M (2020) NUS1 mutation in a family with epilepsy, cerebellar ataxia, and tremor. Epilepsy Res 164:106371
Edani BH, Grabińska KA, Zhang R, Park EJ, Siciliano B, Surmacz L, Ha Y, Sessa WC (2020) Structural elucidation of the cis-prenyltransferase NgBR/DHDDS complex reveals insights in regulation of protein glycosylation. Proc Natl Acad Sci USA 117(34):20794–20802
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The project was approved by the Ethical Committee of the First Affiliated Hospital of Zhejiang University, School of Medicine.
Informed consent
Written informed consents were obtained from the patient’s parents.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ji, C., Zhao, J., Zhang, J. et al. Novel NUS1 variant in a Chinese patient with progressive myoclonus epilepsy: a case report and systematic review. Neurol Sci 44, 3495–3498 (2023). https://doi.org/10.1007/s10072-023-06851-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-023-06851-4